徐兵兵,2022年6月毕业于浙江大学生命科学学院，获得生物化学与分子生物学专业博士学位。博士期间主要从事唐氏综合征细胞黏附分子(Dscam1)基因可变剪切的调控机制研究，以及Dscam1蛋白亚型在神经发育中的功能研究。2022年8月加入西湖大学基因组学与生物信息学核心实验室，从事博士后研究工作。

Bingbing Xu had graduated with a PhD of the biochemistry and molecular biology from the college of life sciences, Zhejiang University in June 2022. Dr. Xu was mainly engaged in the regulation mechanism of the cell adhesion molecule Dscam1 alternative splicing in Down Syndrome, and the Dscam1 protein isoforms function in neural development. In August 2022, Dr. Xu joined the core laboratory of  genomics and bioinformatics of the Westlake University, and he would be engageing in post-doctoral research.